Related Experiment Videos
Calciphylaxis: a systematic review of existing and emerging therapies
Chetan Vedvyas1, Laura S Winterfield, Ruth Ann Vleugels
1Harvard Medical School, Boston, Massachusetts 02115, USA. chetan@post.harvard.edu
Abstract:
Calciphylaxis, also known as calcific uremic arteriolopathy, is a cutaneous ischemic small vessel vasculopathy seen in 1 to 4% of patients with chronic kidney disease on hemodialysis. It is associated with extreme pain and a 60 to 80% mortality rate in the setting of few and frequently ineffective therapeutic options, although this may be changing based on reports of success with newer therapies.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Connective Tissue Cell Types
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Desensitization and Tachyphylaxis
Several...
Chronic Kidney Disease III: Interprofessional Care
Nephrotic Syndrome III : Nursing Management
Chronic Kidney Disease II: Clinical Manifestations